Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation

被引:83
作者
Jiménez-Sainz, MC
Fast, B
Mayor, F
Aragay, AM [1 ]
机构
[1] Univ Bergen, Fac Med, Dept Anat & Cell Biol, N-5009 Bergen, Norway
[2] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, Madrid, Spain
关键词
D O I
10.1124/mol.64.3.773
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs) initiate diverse downstream signaling events in response to ligand stimulation, as rapid activation of the extracellular signal-regulated kinase ERK1 and ERK2. The chemokine monocyte chemoattractant protein-1 (MCP-1) is the agonist for several chemokine receptors that belong to the GPCR superfamily, CCR2 being the most important. Stimulation of mitogen-activated protein kinases (MAPKs) by MCP-1 has been implicated in integrin activation and chemotaxis, but the molecular pathways downstream of the receptors remain unclear. To dissect the cascade of events leading to MAPK activation upon CCR2 receptor stimulation, several specific inhibitors and mutants of signal transduction proteins were used in monocytic cells endogenously expressing CCR2 and/or in human embryonic kidney-293 cells transfected with CCR2B receptors and epitope-tagged ERK1. We show that ERK activation by MCP-1 involves heterotrimeric G(i) protein subunits, protein kinase C, phosphoinositide-3-kinase, and Ras. On the other hand, the activity of cytosolic tyrosine kinases, epidermal growth factor receptor transactivation, or variations in intracellular calcium levels are not required for the mitogenic activation elicited by MCP-1. In addition, we find that internalization of CCR2B itself is not necessary for efficient MCP-1-induced activation of ERK, although a dynamin mutant partially inhibits ERK stimulation. These results suggest that different parallel pathways are being activated that lead to the full activation of the mitogen-activated protein kinase cascade and that internalization of other signaling proteins but not of the receptor is required for complete ERK activation.
引用
收藏
页码:773 / 782
页数:10
相关论文
共 40 条
[1]   Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2 [J].
Aragay, AM ;
Mellado, M ;
Frade, JMR ;
Martin, AM ;
Jimenez-Sainz, MC ;
Martinez-A, C ;
Mayor, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) :2985-2990
[2]   Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B:: Evidence that directed migration is mediated by βγ dimers released by activation of Gαi-coupled receptors [J].
Arai, H ;
Tsou, CL ;
Charo, IF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14495-14499
[3]   Differential regulation of G-protein-mediated signaling by chemokine receptors [J].
Arai, H ;
Charo, IF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (36) :21814-21819
[4]   Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis [J].
Ashida, N ;
Arai, H ;
Yamasaki, M ;
Kita, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :16555-16560
[5]  
Bernstein HG, 1998, CELL MOL BIOL, V44, P973
[6]   Activation of the mitogen-activated protein kinase pathway by a Gq/11-coupled muscarinic receptor is independent of receptor internalization [J].
Budd, DC ;
Rae, A ;
Tobin, AB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12355-12360
[7]   Direct binding of activated c-Src to the β3-adrenergic receptor is required for MAP kinase activation [J].
Cao, WH ;
Luttrell, LM ;
Medvedev, AV ;
Pierce, KL ;
Daniel, KW ;
Dixon, TM ;
Lefkowitz, RJ ;
Collins, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) :38131-38134
[8]   MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF 2 MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTORS REVEALS ALTERNATIVE SPLICING OF THE CARBOXYL-TERMINAL TAILS [J].
CHARO, IF ;
MYERS, SJ ;
HERMAN, A ;
FRANCI, C ;
CONNOLLY, AJ ;
COUGHLIN, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2752-2756
[9]  
Dubois PM, 1996, J IMMUNOL, V156, P1356
[10]  
Ferguson SSG, 2001, PHARMACOL REV, V53, P1